Clinical Trials on 应用部位不适 in Brazil
总计1163个结果
-
Instituto do Cancer do Estado de São Paulo未知
-
Hospital das Clínicas de Ribeirão PretoBristol-Myers Squibb; Fundação de Amparo à Pesquisa do Estado de São Paulo招聘中
-
Hospital Sírio-Libanês完全的
-
Barretos Cancer HospitalUniversity of Campinas, Brazil; AC Camargo Cancer Center未知
-
Instituto Brasileiro de Controle do CancerWecare Comércio de Cosméticos招聘中
-
University of Sao PauloInstituto do Cancer do Estado de São Paulo; Hospital A.C. Camargo完全的
-
AC Camargo Cancer Center未知结肠癌 IIb 期 | 直肠癌, 腺癌 | 结肠癌 IIIa 期 | 结肠癌 IIIc 期 | 结肠癌 IIIb 期巴西
-
D'Or Institute for Research and EducationHalioDx; Diagnosticos da America SA招聘中
-
AC Camargo Cancer CenterInternational Atomic Energy Agency完全的
-
Instituto de Investigação em ImunologiaButantan Institute未知
-
University of Sao Paulo General Hospital招聘中
-
Instituto Nacional de Cancer, Brazil完全的
-
University of Sao Paulo General HospitalHospital Israelita Albert Einstein; Universidade Federal Fluminense招聘中
-
Federal University of Minas GeraisMater Dei Hospital, Brazil未知
-
Hospital de Clinicas de Porto Alegre招聘中
-
Janssen Research & Development, LLC批准上市
-
Instituto do Cancer do Estado de São PauloUniversity of Sao Paulo General Hospital终止
-
University of Sao Paulo未知
-
Instituto Nacional de Cancer, Brazil完全的
-
ColubrisMXFaculdade de Medicina do ABC完全的
-
Barretos Cancer HospitalQIAGEN Gaithersburg, Inc完全的
-
Instituto do Cancer do Estado de São PauloMinistry of Health, Brazil; Fundação Faculdade de Medicina未知
-
Instituto do Cancer do Estado de São PauloUniversity of Sao Paulo完全的
-
Hospital Moinhos de VentoFederal University of Health Science of Porto Alegre未知
-
Astellas Pharma Global Development, Inc.完全的急性髓系白血病 (AML) | 具有 FMS 样酪氨酸激酶 (FLT3)/内部串联重复 (ITD) 突变的急性髓性白血病台湾, 波兰, 塞尔维亚, 美国, 巴西, 加拿大, 捷克语, 丹麦, 法国, 德国, 希腊, 匈牙利, 以色列, 意大利, 日本, 大韩民国, 葡萄牙, 罗马尼亚, 西班牙, 瑞典, 英国